02491nam 2200349 450 991058029920332120230430151325.01-68571-047-6(CKB)5600000000474036(NjHacI)995600000000474036(EXLCZ)99560000000047403620230430d2022 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierDis/cord Thinking Sound through Agential Realism /Kevin Toksöz FairbairnBrooklyn, New York :Punctum Books,2022.1 online resource (xiv, 146 pages)dis/cord is an experiment in reading sound. Embarking from Karen Barad's early work on agential realism, it diffracts quantum physics through sound art, finding the sympathetic resonances that allow them to speak together. dis/cord believes in the materialism of sound, and strives not to understand it, but to become entangled with it. It asserts that impartial observation is impossible and understands immersion as a participatory and collaborative act. Sound art pieces provide the backdrop for a series of reflections on space, time, and matter. They trace the "marks on bodies" that sound leaves behind in its ephemeral vibration, finding new forms of sensation and interpretation through the pain and hearing loss that a life devoted to sound can cause. Drifting between sound studies, artistic research, musicology, and craftsmanship, dis/cord uses agential realism as a platform to approach thinking with, through, and about sound. Following Barad's commitment to diffraction as a form of critique, it superposes a variety of sounds and ideas in the hope that their consonances and dissonances can provoke new ways of engaging with sound as a cultural and material agent. It is neither an appeal to scientist positivism nor a mystical immersion in listening. Rather, it builds from the intertwined physical and metaphysical curiosities that characterize Barad's work, proposing a corporeal engagement with the disjointed temporal and spacial (dis)continuities that sonic materialism helps to build, understand, and create.Dis/cordSound artSound art.709.04074Fairbairn Kevin Toksöz1352699NjHacINjHaclBOOK9910580299203321Dis3195202UNINA04309nam 2200601 450 991013608820332120161111160011.01-5225-1041-910.4018/978-1-5225-1040-6(CKB)3710000000915380(MiAaPQ)EBC4721467(CaBNVSL)gtp00566546(OCoLC)962445467(IGIG)00156642(EXLCZ)99371000000091538020161109d2017 fy 0engurbn||||m|||ardacontentrdamediardacarrierComparative approaches to biotechnology development and use in developed and emerging nations /Tomas Gabriel Bas and Jingyuan Zhao, editorsHershey, Pennsylvania :IGI Global,2017.©2017PDFs (591 pages) illustrationsAdvances in Bioinformatics and Biomedical Engineering (ABBE) Book Series,2327-70411-5225-1040-0 Includes bibliographical references and index.Nutraceutical industry with the collaboration of biotechnology and nutrigenomics engineering: the significance of intellectual property in the entrepreneurship and scientific research ecosystems / Tomas Gabriel Bas -- Bioinformatics: the convergence between biotechnology and ITC impacts on the productive sector / Jorge E. Niosi -- Influence of star bioscientists on obtaining venture capital for Canadian dedicated biotechnology firms / Johanne Queenton, Sophie Veilleux -- A romance of the three kingdoms: biotechnology clusters in Beijing, Shanghai and Guangdong Province, China / Petr Hanel [and 4 others] -- Is collaboration important at all stages of the biotechnology product development process? / Catherine Beaudry -- Entrepreneurial approach to biotechnology policies and development in India / Neeta Baporikar -- Institutions as enablers of science-based industries: the case of biotechnology in Mexico / Marcia Villasana -- A new tool for supporting innovation in biotech co-innovation and the role of economic developers / Marina Frangioni -- The Turkish biotechnology system: functioning or malfunctioning? / Dilek Cetindamar -- Importance of biotechnology in the development of functional foods in emerging countries: the case of Chile / Carolina Alejandra Oliu -- What influences the growth of Canadian biotechnology firms? / Catherine Beaudry, Joël Levasseur -- Corporate social responsibility of pharmaceutical industry towards access to medicine: a case study of GlaxoSmithKline / Rakhi Rashmi -- Collaboration, innovation, and funding as survival factors for Canadian biotechnology SMEs / Catherine Beaudry, Joël Levasseur -- The competitive and comparative advantages effectively fostered by national innovation systems: an exploratory study / Silvia Ivonne Ponce, Mauricio Poblete Bustamante, Tomas Gabriel Bas -- Regional innovation pattern: a case of Beijing biopharmaceutical industrial clusters / Jingyuan Zhao -- Is China catching up?: health-related applications of biotechnology / Petr Hanel."This book evaluates the importance of manufacturing biotechnological products around the world, highlighting a comparative analysis of public policies, technological policies, innovations, and marketing capability of developed and emerging nations"--Provided by publisher.Advances in bioinformatics and biomedical engineering book series.BiotechnologyDeveloping countriesBiotechnologyGovernment policyDeveloped countriesEconomic developmentEntrepreneurshipNutraceuticalsProduct developmentSupply chainTechnological innovationBiotechnologyBiotechnologyGovernment policy660.609172/4Bas Tomas Gabriel1964-1248571Bas Tomas Gabriel1964-Zhao Jingyuan1968-CaBNVSLCaBNVSLCaBNVSLBOOK9910136088203321Comparative approaches to biotechnology development and use in developed and emerging nations2893768UNINA